Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
hace 815
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
hace 1081
Bay Street Likely To Open On Mixed Note
Canadian shares are likely to open on a mixed note on Thursday, tracking earnings updates, and commodity prices. The end to the U.S. government shutdown following President Donald Trump signing a short term bill is likely to aid sentiment.
RTTNews
|
hace 3h 12min
European Stocks Pare Early Gains As Markets Digest Earnings, Economic News
European stocks gave up early gains and are broadly lower Thursday afternoon as investors look ahead to some crucial economic data following the longest federal government shutdown in U.S. history coming to an end after President Donald Trump signed a funding package.
RTTNews
|
hace 3h 38min
Disney Q4 Profit Beats Street, Revenues Miss; Sees Adj. EPS Growth, Plans $7 Bln Buyback; Stock Down
Shares of Walt Disney Co. were losing around 4 percent in the pre-market activity on Thursday after the media and entertainment major reported nearly flat revenues in its fourth quarter below market estimates, even though profit beat the Street. Further, the firm said it expects double digit year-over-year growth in adjusted earnings per share for fiscal 2026 and 2027, and targets doubling share
RTTNews
|
hace 3h 51min
FTSE 100 Moderately Lower At Noon As Investors React To Earnings, GDP Data
U.K.'s benchmark FTSE 100 is down in negative territory around noon on Thursday with investors digesting a slew of earnings updates, and data showing a marginal increase in the nation's economic growth in the third quarter.
RTTNews
|
hace 4h 32min
UK Economy Logs Marginal Growth
The UK economy logged only a marginal growth in third quarter as the cyber attack on Jaguar Land Rover hit production, official data revealed on Thursday. Gross domestic product grew 0.1 percent sequentially, following the prior quarter's 0.3 percent expansion, the Office for National Statistics reported Thursday. Output was expected to advance 0.2 percent.
RTTNews
|
hace 4h 34min
CAC 40 Rises 0.5%; Bank, Luxury Stocks Shine
France's CAC 40 rose to a record high Thursday morning as stocks climbed higher, reacting to U.S. President Donald Trump signing a bill to end the longest government shutdown in history. Expectations of an interest rate cut by the Federal Reserve next month contribute as well to market's positive move.
RTTNews
|
hace 5h 17min
